Created at Source Raw Value Validated value
June 25, 2024, noon usa

* known or highly suspected bacterial infection (antibiotic treatment to avoid bacterial superinfection may be allowed) * pct ≥ 1μg/l * mechanical ventilation * inability to conduct inhalation therapy * hemodynamic instability with requirement of vasopressor therapy * severe comorbidities interfering with the safe participation at the trial according to the treating physician * pregnancy * systemic immunosuppression

* known or highly suspected bacterial infection (antibiotic treatment to avoid bacterial superinfection may be allowed) * pct ≥ 1μg/l * mechanical ventilation * inability to conduct inhalation therapy * hemodynamic instability with requirement of vasopressor therapy * severe comorbidities interfering with the safe participation at the trial according to the treating physician * pregnancy * systemic immunosuppression

Oct. 26, 2020, 11:31 p.m. usa

- known or highly suspected bacterial infection (antibiotic treatment to avoid bacterial superinfection may be allowed) - pct ≥ 1μg/l - mechanical ventilation - inability to conduct inhalation therapy - hemodynamic instability with requirement of vasopressor therapy - severe comorbidities interfering with the safe participation at the trial according to the treating physician - pregnancy - systemic immunosuppression

- known or highly suspected bacterial infection (antibiotic treatment to avoid bacterial superinfection may be allowed) - pct ≥ 1μg/l - mechanical ventilation - inability to conduct inhalation therapy - hemodynamic instability with requirement of vasopressor therapy - severe comorbidities interfering with the safe participation at the trial according to the treating physician - pregnancy - systemic immunosuppression